Indivior Pharmaceuticals, Inc. Share Price
Stocks
INDV
US45579U1097
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.54 USD | -0.12% |
|
+0.10% | +12.99% |
| 29/06 | Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Value-Defensive Index | CI |
| 29/06 | Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Growth-Defensive Index | CI |
| Market Cap | 494.27Cr 431.94Cr 398.59Cr 367.4Cr 692.48Cr 48TCr 707.85Cr 4.76TCr 1.87TCr 23TCr 1.86TCr 1.82TCr 80TCr | P/E 2026 * |
12.8x | P/E 2027 * | 11.2x |
|---|---|---|---|---|---|
| Enterprise Value | 499.72Cr 436.71Cr 402.98Cr 371.45Cr 700.11Cr 48TCr 715.65Cr 4.82TCr 1.89TCr 24TCr 1.88TCr 1.84TCr 81TCr | EV / Sales 2026 * |
3.97x | EV / Sales 2027 * | 3.46x |
| Free-Float |
97.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | -0.12% | ||
| 1 week | +0.10% | ||
| Current month | -1.19% | ||
| 1 month | +5.85% | ||
| 3 months | +23.98% | ||
| 6 months | +24.59% | ||
| Current year | +12.99% |
| 1 week | 39.25 |  | 41.84 |
| 1 month | 37.64 | | 42.81 |
| Current year | 27.68 | | 42.81 |
| 1 year | 15.55 | | 42.81 |
| 3 years | 7.33 | | 42.81 |
| 5 years | 7.33 | | 42.81 |
| 10 years | 1.75 | | 42.81 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/07/26 | Sell | Chief Scientific Officer | -18,586 | 0.0152% | ||
| 22/06/26 | Fiscal year | Chief Executive Officer | 31,46,355 | 2.5806% | ||
| 11/06/26 | Sell | Chief Scientific Officer | -18,586 | 0.0152% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.12% | +0.10% | +153.22% | +74.82% | 494.27Cr | |
| +0.85% | -0.80% | +52.79% | +161.33% | 1,05100Cr | |
| +1.23% | -1.53% | +54.58% | +59.08% | 61TCr | |
| +0.04% | +2.58% | +34.47% | +86.33% | 45TCr | |
| +0.78% | -0.71% | +29.28% | +24.10% | 33TCr | |
| +1.41% | +0.58% | +35.44% | +40.67% | 28TCr | |
| -0.27% | -1.87% | +22.34% | +22.51% | 26TCr | |
| -1.76% | +2.37% | -20.43% | -38.00% | 22TCr | |
| -1.42% | +0.80% | +24.27% | +57.50% | 20TCr | |
| -1.48% | +3.43% | +24.08% | +71.67% | 17TCr | |
| Average | -0.07% | +0.49% | +41.00% | +56.00% | 35.8TCr | |
| Weighted average by Cap. | +0.37% | +0.02% | +37.67% | +79.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 126.01Cr 110.12Cr 101.62Cr 94Cr 176.54Cr 12TCr 180.46Cr 1.21TCr 477.72Cr 5.94TCr 473.23Cr 462.85Cr 20TCr | 131.24Cr 114.69Cr 105.84Cr 98Cr 183.87Cr 13TCr 187.95Cr 1.27TCr 497.56Cr 6.19TCr 492.89Cr 482.07Cr 21TCr |
| Net income | 41Cr 36Cr 33Cr 31Cr 58Cr 3.99TCr 59Cr 399.49Cr 157.13Cr 1.95TCr 155.65Cr 152.24Cr 6.73TCr | 47Cr 41Cr 38Cr 35Cr 66Cr 4.55TCr 68Cr 455.78Cr 179.27Cr 2.23TCr 177.59Cr 173.69Cr 7.68TCr |
| Net Debt | 5.45Cr 4.76Cr 4.39Cr 4.05Cr 7.64Cr 524.84Cr 7.8Cr 53Cr 21Cr 257.05Cr 20Cr 20Cr 884.88Cr | -40Cr -35Cr -33Cr -30Cr -57Cr -3.88TCr -58Cr -388.82Cr -152.93Cr -1.9TCr -151.5Cr -148.17Cr -6.55TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | $40.54 | -0.12% | 9,84,698 |
| 16/26/16 | $40.59 | -0.83% | 17,46,666 |
| 15/26/15 | $40.93 | +1.74% | 18,70,240 |
| 14/26/14 | $40.23 | +0.05% | 9,92,052 |
| 13/26/13 | $40.21 | -0.72% | 12,34,601 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
